CD1-MR1 2025 Shinichiro Motohashi
Chiba University, JAPAN, Japan
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Remembering Dr. Masaru Taniguchi – His Contributions to iNKT Cell Research (#49)
2:00 PM
Shinichiro Motohashi
Tribute to Masuru Taniguchi
Single-cell analysis results of the patient's blood in the phase I clinical trial of allogeneic iPS cell-derived invariant NKT cell monotherapy (#151)
12:30 PM
Takahiro Aoki
Lunch & Poster Session 2
Antibody-dependent cellular cytotoxicity of iPS cell-derived natural killer T cells by anti-GD2 mAb for neuroblastoma (#20)
4:47 PM
Katsuhiro Nishimura
Lightning Talks 1
Blockade of AhR signaling augments the efficacy of NKT cell-based immunotherapy (#172)
12:30 PM
Mariko Takami
Lunch & Poster Session 2